Durgical
EN
Open the app

Autoimmune haemolysis: warm, cold and drug-induced

  • Look-alikes compared

The body can make antibodies that destroy its own red cells. Whether they work warm or cold decides the cause, the smear and which treatment works.

Updated

What it is

Autoimmune haemolytic anaemia is red cell destruction by the patient's own antibodies, shown by a positive direct antiglobulin test (DAT, direct Coombs). Warm antibodies (usually IgG) bind at body temperature and the spleen removes the coated cells. Cold agglutinins (usually IgM) bind in the cool skin of hands, feet, nose and ears, fix complement and clump the cells. Paroxysmal cold haemoglobinuria is caused by an IgG antibody that binds in the cold and bursts the cells when they warm. Drugs can trigger any of these patterns.

The difference in one line

  • Warm AIHA: the commonest form; DAT positive for IgG (with or without C3); spherocytes; about half are secondary (chronic lymphocytic leukaemia, lymphoma, lupus, other autoimmune disease, drugs).
  • Cold agglutinin disease: DAT positive for C3 only; clumped cells on the smear, acrocyanosis and worse haemolysis in cold weather; primary forms are a small B-cell clone, secondary forms follow Mycoplasma pneumoniae, Epstein–Barr virus or lymphoma.
  • Paroxysmal cold haemoglobinuria: mostly young children after a viral infection; sudden intravascular haemolysis with dark urine; the Donath–Landsteiner test shows the biphasic antibody; usually self-limited.
  • Drug-induced: the antibody may need the drug present (some cephalosporins such as ceftriaxone, piperacillin) or act alone (methyldopa); stopping the drug is the key treatment.
  • Evans syndrome is autoimmune haemolysis with immune thrombocytopenia (and sometimes neutropenia); look for an underlying immune disorder.

Warm, cold or drug

FeatureWarm AIHACold agglutinin diseaseParoxysmal cold haemoglobinuriaDrug-induced
AntibodyIgG, binds at body temperatureIgM, binds in the cold, fixes complementIgG (Donath–Landsteiner), binds cold, lyses on warmingDrug-dependent or drug-induced autoantibody
DATIgG ± C3C3 onlyC3 (IgG often not detected)IgG and/or C3
Where cells dieSpleen (extravascular)Liver mainly; some intravascularInside the vesselsSpleen or vessels, by drug
Smear and analyserSpherocytesRed cell clumps; falsely high MCV and low countVariable; haemoglobinuriaSpherocytes or intravascular picture
Typical patientAdults; CLL, lymphoma, lupusOlder adults; after Mycoplasma or EBVChild after a viral illnessRecent new drug, often an antibiotic
First treatmentGlucocorticoids; rituximab nextAvoid cold, warm infusions; rituximab-based or complement-blocking treatmentSupportive, keep warm, transfuse if neededStop the drug

In clinical practice

  • Never withhold transfusion in life-threatening autoimmune haemolysis because the crossmatch is 'incompatible': the blood bank provides the best-matched units and the haematologist decides.
  • Patients with cold agglutinins need blood and fluids warmed through a blood warmer, and a warm room; cooling during surgery can trigger haemolysis.
  • Warm AIHA raises the risk of venous thrombosis; prevention is considered during flares.
  • Look for the cause in every warm or cold case: lymph nodes and spleen, protein electrophoresis, lupus serology, viral tests, and the drug list.
  • Steroids and splenectomy work poorly in cold agglutinin disease because the liver, not the spleen, removes the complement-coated cells.

How it is confirmed

  • Haemolysis panel (reticulocytes, LDH, bilirubin, haptoglobin) and smear, then the DAT with IgG and C3 specificity.
  • DAT C3 only: cold agglutinin titre and thermal amplitude on a sample kept warm; in children with dark urine, the Donath–Landsteiner test.
  • Clumped cells and a strangely high MCV: rerun the count on a warmed sample before trusting the indices.
  • Warm AIHA: protein electrophoresis, CT or examination for nodes and spleen, lupus antibodies, and peripheral blood flow cytometry if CLL is possible.
  • Suspected drug cause: stop it and ask the reference laboratory for drug-dependent antibody testing.

Common traps

  • Treating cold agglutinin disease like warm AIHA with steroids and splenectomy: they seldom help.
  • Trusting the MCV and red cell count in a sample with cold agglutinins: clumps are counted as giant single cells.
  • Ruling out autoimmune haemolysis because the DAT is negative: a small proportion of cases are DAT-negative and need more sensitive tests.
  • Forgetting a recent transfusion: a new positive DAT may be a delayed haemolytic reaction, not autoimmunity.
  • Missing ceftriaxone as a cause of haemolysis: it can cause sudden, severe intravascular haemolysis, especially in children and in patients with sickle cell disease.

Test yourself

Think of the answer, then tap the question to see it.

The DAT shows complement (C3) but no IgG. Which kind of autoimmune haemolysis do you suspect, and why is no antibody seen?

A cold antibody: the IgM (or Donath–Landsteiner IgG) binds in the cold, fixes complement, then falls off at body temperature, leaving only C3 on the cell.

Why do steroids and splenectomy help warm AIHA but not cold agglutinin disease?

In warm AIHA IgG-coated cells are removed in the spleen; in cold agglutinin disease complement-coated cells are cleared mainly in the liver, and the IgM clone responds poorly to steroids.

A patient's analyser report shows an MCV far above normal and a very low red cell count, and the smear shows clumps. What do you do?

Suspect cold agglutinins and repeat the count on a sample warmed to body temperature; the clumps are being counted as single giant cells.

A child develops dark urine and pallor a week after a cold. The DAT shows C3 only. Which test confirms the cause?

The Donath–Landsteiner test, which shows an IgG antibody that binds red cells in the cold and lyses them with complement on warming: paroxysmal cold haemoglobinuria.

Add to my cards (4)

Elsewhere in DurgiPedia

Connections

← All of haematology

Educational content; it does not replace assessment by a doctor or your institution's protocols. It contains no doses.

Sources: Immune hemolytic anemia (MedlinePlus, US National Library of Medicine, 2026); Coombs test (MedlinePlus (U.S. National Library of Medicine), 2024); Hemolytic anemia (MedlinePlus, US National Library of Medicine, 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.